• Arrowstreet Capital disclosed a 0.92% net short position in Abivax.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.